Sanket Koul, Business Standard

Stories by Sanket Koul, Business Standard

Is The Worst Over For IT Industry?

Is The Worst Over For IT Industry?

Rediff.com   25 Jan 2024

Certain changes in the past two or three years could have a long-term structural impact on the IT services market.

2023: 2nd Warmest Year Since 1901

2023: 2nd Warmest Year Since 1901

Rediff.com   12 Jan 2024

The five warmest years in Indian weather history have occurred in the past 14 years -- the others being 2009, 2017 and 2010, in order of intensity.

Stock Market: Which Sectors Delivered?

Stock Market: Which Sectors Delivered?

Rediff.com   12 Jan 2024

The biggest bounce is in the realty sector, where the industry index jumped 80%. There's been a turnaround also in automobiles and ancillaries (up 45%). The pharma and health care indices have a welcome return of roughly 35%.

Revised Schedule M elicits mixed response

Revised Schedule M elicits mixed response

Rediff.com   8 Jan 2024

A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.

The IPL's Pay Problem

The IPL's Pay Problem

Rediff.com   1 Jan 2024

Lower-paid IPL players, domestic or foreign, should be able to try their luck in other T20 tournaments.

Good News For Android App Developers

Good News For Android App Developers

Rediff.com   30 Dec 2023

For many developers, it may not be a sufficient saving to make it worth creating and maintaining alternatives.

Are hospitals ready to handle Covid surge?

Are hospitals ready to handle Covid surge?

Rediff.com   26 Dec 2023

Larger hospitals are not worried about a spike in cases, as they are now accustomed to converting ICUs and general wards into negative pressure zones or isolation rooms. For smaller hospitals, the task is tedious.

2024 Challenge For INDIA Grows Every Day!

2024 Challenge For INDIA Grows Every Day!

Rediff.com   18 Dec 2023

If they wish to have any chance next year, the Congress and the alliance must quickly settle all issues, draw up an alternative agenda, and create a cohesive campaign.

Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles

Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles

Rediff.com   20 Nov 2023

Pharmaceuticals major Mankind Pharma reported a 21 per cent year-on-year (Y-o-Y) increase in net profit, with revenue rising by 12 per cent Y-o-Y in the second quarter of the financial year 2024 (Q2FY24) in a regulatory filing lrecently.

'We are building Kia 2.0. India is a long-term bet for us'

'We are building Kia 2.0. India is a long-term bet for us'

Rediff.com   17 Nov 2023

'India is the sixth-largest market for the Kia Corporation, and contributes 8 to 9 per cent to our global sales.' 'We are eyeing 10 per cent market share over the next few years depending on customer demand and new product innovations.'

IKS Health, backed by Jhunjhunwala family, buys US tech firm for Rs 1,600 cr

IKS Health, backed by Jhunjhunwala family, buys US tech firm for Rs 1,600 cr

Rediff.com   1 Nov 2023

AQuity Solutions is a leading tech-enabled clinical documentation, medical coding and revenue integrity solutions provider in the healthcare domain. On the other hand, IKS Health provides administrative, clinical and operational services to clinicians.

Israel conflict unlikely to impact trade of pharma firms

Israel conflict unlikely to impact trade of pharma firms

Rediff.com   12 Oct 2023

Indian pharmaceutical firms foresee minimal disruptions in trade with Israel despite escalating regional tensions. Rising crude prices and export shipping insurance premiums have raised concerns, but the pharmaceutical sector remains optimistic. Pharmaceutical exports from India to Israel in FY 2020-21 amounted to $32.5 million, which represents only a minor segment of India's overall pharma exports.

Budget 2023: Here are the key challenges in technology sector

Budget 2023: Here are the key challenges in technology sector

Rediff.com   23 Jan 2023

"India is the best market right now in the world with the digital initiatives the government has implemented

'India is on a good wicket now'

'India is on a good wicket now'

Rediff.com   10 Jan 2023

'The pitch for India is flat, the ball for India is old, the sun for India is out, and the bowlers are not bowling too well.' 'I think only we can get ourselves out.'

'A slip-up can break trust of investors'

'A slip-up can break trust of investors'

Rediff.com   3 Jan 2023

'Strong regulations are crucial for the orderly development of the market.'

IPO Fundraising Dipped To Half in 2022

IPO Fundraising Dipped To Half in 2022

Rediff.com   3 Jan 2023

The turmoil in the markets has been cited as the reason for the dip in the IPO market.

How Covid Spiked Gold Smuggling

How Covid Spiked Gold Smuggling

Rediff.com   3 Jan 2023

Officials were surprised at how quickly smugglers appraised the Covid situation to recruit jobless migrant workers to ship gold.

When Pelemania Gripped India

When Pelemania Gripped India

Rediff.com   2 Jan 2023

The enormous structured global advertising machinery that surrounds every football game on the planet today? Pele was perhaps single-handedly responsible for all of it. By just being brilliant, captivating crowds, and behaving like a being from the future, doing things that STILL provoke oohs and aahs from watchers. Vaibhav Raghunandan salutes the Incomparable Pele.

EV Sales May Cross 100,000 Monthly, But...

EV Sales May Cross 100,000 Monthly, But...

Rediff.com   2 Jan 2023

China's covid crisis could provoke a raw material crunch for India's EV industry later this year.

How Will Gold Perform In 2023?

How Will Gold Perform In 2023?

Rediff.com   2 Jan 2023

Given the prevailing uncertainties, investors must maintain a 10-15 per cent allocation to gold in 2023.